B Vitamin Therapy for Parkinson's Disease Management
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
- Age
- 40 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- Oregon Health and Science University · Other
This trial is looking for people with Parkinson's disease who are taking levodopa. Participants will receive B vitamin therapy to see if it can help lower their homocysteine levels and improve thinking skills.
You may be able to join if
- I have been diagnosed with Parkinson's disease.
- I take at least 300 mg of levodopa every day.
- I am between 40 and 90 years old.
- I have a cognitive assessment score of at least 15.
- I can give informed consent.
- My kidney function is normal.
- I do not have uncontrolled high blood pressure.
You may not be able to join if
- I use insulin.
- I have uncontrolled hypertension.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis is a research study investigating elevated homocysteine in the blood of patients with Parkinson's disease who are currently receiving treatment with levodopa. We are evaluating if elevated homocysteine can be corrected using open label B vitamin therapy, as well as the impact of homocysteine levels on cognitive function.
Loading trial locations…